Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma. Uchimoto T, Fukushima T, Komura K, Fukuokaya W, et al. BJU Int 2023;131:477-485.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Uchimoto T, Fukushima T, Komura K, Fukuokaya W, et al. Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma. BJU Int 2023;131:477-485.
PMID: 36098556